For Most Older Cancer Patients, Feeling Well Beats Living Longer. The Healthcare System Disagrees

Only 1 in 12 older adults with advanced cancer say extending their life is their top priority. Most of the rest say feeling well matters more, or at least more than surviving longer at any cost.

That’s the central finding of a new study published in JAMA Oncology, and it challenges a long-held assumption in cancer medicine: that patients will fight for every extra day, no matter the cost to their comfort. Among 706 adults aged 70 and older with incurable cancer, nearly 72 percent said maintaining quality of life mattered more to them than living longer. Just 8.4 percent said the opposite.

The number that should prompt the most serious reflection, though, isn’t the one about patient preferences. It’s what happened after those preferences were recorded. Whether a patient wanted to feel better or live longer, their actual care looked almost identical.

Most Older Cancer Patients Prioritize Quality of Life Over Survival

Researchers drew on data from the GAP70+ trial, a large clinical study conducted at National Cancer Institute Community Oncology Research Program centers between 2014 and 2019. All 706 participants were 70 or older, had an incurable solid tumor or lymphoma diagnosis, and were about to begin a new cancer treatment carrying a high risk of serious side effects. The average age was around 77. Slightly more than half were male, and nearly 88 percent identified as non-Hispanic White. Gastrointestinal, lung, and genitourinary cancers were the most common diagnoses.

At enrollment, each patient responded to a single statement: “Maintaining my quality of life is more important to me than living longer.” Their answer placed them into one of two groups. Of the 706 patients, 506 said quality of life was the priority. Only 59 said survival was. The remaining 141 had no clear preference either way.

When What Patients Want Doesn’t Change What They Get

Researchers went in with a reasonable prediction. Patients who wanted to live longer would push through more aggressive treatment and might survive longer as a result. Patients who prioritized comfort would have their regimens scaled back, leading to fewer severe side effects and fewer hospital stays. The data dismantled both expectations.

Across every outcome the researchers tracked, the two groups looked essentially the same. Patients who wanted to survive longer were no more likely to be alive at six months or one year. Patients who prioritized quality of life were no less likely to land in the hospital or suffer from serious treatment side effects. Treatment adjustments happened at nearly the same rate in both groups regardless of what a patient said they wanted.

In this study, patients who said they prioritized quality of life did not end up receiving meaningfully different care from those who said they wanted to live longer.

The authors point to structural reasons for that disconnect. Prior research cited in the paper found that oncologists ask patients what matters most to them before selecting a treatment only about one-third of the time. Hospitals and health systems increasingly push physicians toward standardized treatment pathways that reward protocol adherence over individualized decisions. As the paper notes, “structural incentives to enhance productivity/reimbursement increasingly promote adherence to protocolized regimens (eg, pathways) and disincentivize clinicians from tailoring treatments to individual patient preferences.”

There’s also the question of whether “quality of life” is simply too vague to act on. A patient expressing a preference for comfort doesn’t hand a clinician a clear instruction. The broader research pipeline reflects a similar gap: only about 3 percent of all oncology clinical trials over the last 20 years have focused on improving quality of life for patients, according to data cited in the study.

Who Is Most Likely to Say Quality of Life Comes First

A few patterns emerged in who leaned toward quality of life. Patients with at least some college education were more than twice as likely to prioritize it over survival compared to those who stopped at a high school diploma. Patients without cognitive impairment were also more likely to lean that way than those showing signs of cognitive decline.

Age, sex, income, marital status, cancer type, and stage offered no predictive signal. Oncologists cannot reliably infer what a patient values most from a chart. Without a direct conversation, there is no shortcut.

It’s worth noting the cohort was predominantly non-Hispanic White, at nearly 88 percent, which limits how broadly the findings apply. The authors acknowledged that preferences among Black, Indigenous, and other minoritiy groups are not well captured in this dataset.

A Policy Change That Could Shift Cancer Care for Older Adults

A 2024 rule from the Centers for Medicare and Medicaid Services now requires documentation of how older adults’ preferences are incorporated into care plans, a step meant to encourage more preference-concordant care.

Whether that translates into meaningful change in the exam room is an open question. Documentation is not the same as action, and recording a preference is not the same as honoring it.

Most older adults facing an incurable cancer diagnosis aren’t asking for everything medicine has to offer. They’re asking for a say in how their remaining time feels. The data suggests the system, more often than not, isn’t set up to give them one.

---

Disclaimer: This article is based on a secondary analysis of a clinical trial and is intended for general informational purposes only. It does not constitute medical advice. Patients with cancer or other serious illnesses should consult a qualified healthcare provider regarding treatment options and care decisions.

---